Guyton
Guyton v. Novo Nordisk, Inc.
Opinion
Lead Opinion
Morrow, J.
ORDER GRANTING DEFENDANT’S' ” MOTION FOR SUMMARY t JUDGMENT
On September 5, 2014, Andrew Guyton sued Novo Nordisk, Inc. (“Novo Nordisk”) and various fictitious defendants, alleging claims of race and age. discrimination, as well as retaliation, under California’s Fair Employment and Housing Act, Government Code § 12900 et seq. (“FEHA”); he also pled a claim for-wrongful discharge in violation of public policy. 1 Novo Nordisk was served on December 5, 2014, 2 and timely removed the action to federal court on January 2, 2015, invoking the court’s diversity jurisdiction.
On November .16, 2015, Novo Nordisk moved for summary judgment. 4 Guyton opposes the motion.
I. FACTUAL BACKGROUND
A. Novo Nordisk and Its Relevant Policies i
Novo Nordisk is a pharmaceutical company that develops, markets, and sells drugs designed to treat-patients suffering from Type I and Type II diabetes. 6 - As described by one of Novo Nordisk’s managers, Jill Sutton, Novo Nordisk’s sales professionals and sales managers are organized into regions, which iii turn are divided.-up sales districts. The sales districts are divided into sales territories. 7 Regions are overseen by “regional sales directors,”…